Wille, N., Badia, Quality life resolution. 19(6), 875–886 (2010)
Google Scholar
Ravens-Sieberer, U., Wille, N., Badia, Quality life resolution. 19(6), 887–897 (2010)
Google Scholar
Herdman, M., Gudex, C., Lloyd, A., Janssen, MF, Kind, P., Parkin, D., Badia, X.: Development and preliminary testing of a new five-level version of the EQ-5D (EQ-5D-5L). Quality life resolution. 20(2011), 1727-1736 (2011)
Google Scholar
Dolan, P., Gudex, C., Kind, P., Williams, A.: Time trade-off methods: Results from a general population survey. Health economy. 5(2), 141–154 (1996)
Google Scholar
Kreimeier, S., Oppe, M., Ramos-Goñi, JM, Cole, A., Devlin, N., Herdman, M., Greiner, W.: EuroQol five-dimension questionnaire, adolescent version (EQ-5D-Y) and EuroQol five-dimension questionnaire, three-level version (EQ-5D-3L) Assessment of health status: influence of wording and perspective. value health 21(11), 1291~1298(2018)
Google Scholar
Ramos-Goñi, JM, Oppe, M., Stolk, E., K. Pharmacoeconomics. 38653–663 (2020)
Google Scholar
Janssen, BM, Oppe, M., Versteegh, MM, Stolk, EA: Introduction to complex time trade-offs: feasibility and feasibility testing. euro. J. Health Economics. 145–13 (2013)
Google Scholar
Devlin, N., Pan, T., Kreimeier, S., Verstraete, J., Stolk, E., Rand, K., Herdman, M.: EQ-5D-Y assessment: Current state of play. Health Qualifications. results of life 20(1), 1~11(2022)
Pan, T., Roudijk, B., Devlin, N., Mulhern, B., Norman, R.: Australian values set in EQ-5D-Y-3L. Health Qualifications. results of life 23(1), 72(2025)
Google Scholar
Dewilde, S., Roudijk, b. Pharmacoeconomics (S2), (2022). https://doi.org/10.1007/s40273-022-01187-x
Holy Spirit, CM, Miyomoto, GC, Santos, Vs, Ben, â.J., finch, AP, roudjk, b., de Jesus-Maraleida, Fabina Resende, Stein, Airton Teelbom, Santos, Marisa, Yamatating EQ-5d-3l Value Set-3d-3l Value Set-3d-3l Pharmacology (2024). https://doi.org/10.1007/s40273-024-01404-9
Google Scholar
Yang, Z., Jiang, J., Wang, P., Jin; https://doi.org/10.1007/s40273-022-01216-9
Google Scholar
Kreimeier, S., Mott, D., Ludwig, K., Greiner, W.: EQ-5D-Y values established for Germany. Pharmacoeconomics. 40(Supplement 2), 217–229 (2022). https://doi.org/10.1007/s40273-022-01143-9
Rencz, F., Ruzsa, G., Bató, A., Yang, Z., Finch, A.P., Brodszky, V.: Value set for EQ-5D-Y-3L in Hungary. Pharmacoeconomics (2022). https://doi.org/10.1007/s40273-022-01190-2
Google Scholar
Fitriana, TS, Roudijk, B., Purba, FD, Busschbach, jj, Stolk, E.: Estimating eq-5d-y-3l values for Indonesia by mapping periods to tto values. pharmacoeconomics 40(2), 157–167 (2022)
Google Scholar
Shiroiwa, T., Ikeda, S., Noto, S., Fukuda, T., Stolk, E.: Evaluation investigation of EQ-5D-Y based on an international common protocol: development of values established in Japan. Med. decision. making 41(5), 597–606 (2021)
Google Scholar
Roudijk, B., Sajjad, A., Essers, B., Lipman, S., Stalmeier, P., Finch, A.P.: Values established for EQ-5D-Y-3L in the Netherlands. pharmacoeconomics 40(Supplement 2), 193–203 (2022)
Google Scholar
Prevolnik Rupel, V., Ogorevc, M., and IMPACT HTA HRQoL Group. EQ-5D-Y values have been established for Slovenia. pharmacoeconomics, 39(4), 463–471 (2021) http://orcid.org/0000-0001-9552-6969. https://doi.org/10.1007/s40273-022-01143-9s40273-020-00994-4
Ramos-Goñi, JM, Oppe, M., Estévez-Carrillo, A., Rivero-Arias, O., Wolfgang, G., Simone, K., Kristina, Ludwig, Valentina, R.: Evaluating alternative anchoring approaches to account for unobservable preference heterogeneity and estimate country-specific sets of EQ-5D-Y values: a case study using Spanish preference data. value of health 25(5), 835–843 (2022)
Google Scholar
Devlin, N., Roudijk, B., Viney, R., Stolk, E.: EQ-5D-Y-3L value set, evaluation method and conceptual questions. Pharmacoeconomics (2022). https://doi.org/10.1007/s40273-022-01226-7
Google Scholar
Mott, DJ, Devlin, NJ, Kreimeier, S., Norman, R., Shah, KK, Rivero-Arias, O.: Analytical considerations when fixing the values of discrete choice experiments using complex time trade-off data: The case of EQ-5D-Y-3L. Pharmacoeconomics (S2), (2022). https://doi.org/10.1007/s40273-022-01214-x
Roudijk, B., Donders, ART, Stalmeier, PF: Cultural values: can they explain differences in health care utilities across countries? Med. decision. making 39(5), 605–616 (2019)
Google Scholar
Bailey, H., Kind, P.: Preliminary findings from an investigation into the relationship between national culture and EQ-5D value sets. Quality life resolution. 191145~1154 (2010)
Google Scholar
Olsen, JA, Lamu, AN, Cairns, J.: Searching for a common currency: comparing seven sets of EQ‐5D‐5L values. health economy 27(1), 39~49(2018)
Google Scholar
Roudijk, B., Janssen, B., Olsen, J.A.: How do the EQ-5D-5L value sets differ? In: EQ-5D-5L Value Set: Compendium, comparative review and user guide, pp. 235-258. Springer International Publishing, Cham (2022)
Janssen, MF, Pickard, AS, Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, Paul, Busschbach, J.: Measurement properties of the EQ-5D-5L compared with the EQ-5D-3L across eight patient groups: a multinational study. quality of life research 221717~1727 (2013)
Google Scholar
Devlin, N., Roudijk, B., & Ludwig, K. EQ-5D-5L value set: Overview, comparative review, and user guide. (2022)
Devlin, NJ, Pan, T., Sculpher, M., Jit, M., Stolk, E., Rowen, D., van Hout, B., Norman, R.: Using age-specific values for pediatric HRQoL in cost-effectiveness analyses: Are there any issues that need to be addressed? So how? pharmacoeconomics 41(10), 1165~1174(2023)
Google Scholar
Bouckaert, N., Cleem Well, I., Devizean, S., Clempens, S.: EQ-5D-5L values established for Belgium. Pharmacoeconomics-Open 6(6), 823–836 (2022)
Google Scholar
Luo, N., Liu, G., Li, M., Guan, H., Jin, X., Rand-Hendriksen, K.: Estimation of EQ-5D-5L values established in China. value health 20(4), 662–669 (2017)
Google Scholar
Ludwig, K., von der Schulenburg, G., JM, Greiner, W.: German values set for EQ-5D-5L. Pharmacoeconomics. 36663–674 (2018)
Google Scholar
Rencz, F., Brodszky, V., Gulácsi, L., Golicki, D., Ruzsa, G., Pickard, A.S., Law, Ernest H.., Péntek, M.: Parallel evaluation of EQ-5D-3L and EQ-5D-5L under time trade-offs in Hungary. value of health 23(9), 1235~1245(2020)
Google Scholar
Purba, FD, Hunfeld, JA, Iskandarsyah, A., Fitriana, TS, Sadarjoen, SS, Ramos-Goñi, JM, Hunfeld, Joke AM., Passchier, Jan, Busschbach, Jan JV, Busschbach, JJ: Indonesian EQ-5D-5L value set. pharmacoeconomics 351153~1165(2017)
Google Scholar
Shiroiwa, T., Ikeda, S., Noto, S., Igarashi, A., Fukuda, T., Saito, S., Shimozuma, K.: Comparison of value sets based on DCE and/or TTO data: scoring for EQ-5D-5L health status in Japan. value health 19(5), 648–654 (2016)
Google Scholar
Versteegh, MM, Vermeulen, KM, Evers, SM, De Wit, GA, Prenger, R., Stolk, EA: Dutch tariffs for the Stage 5 version of the EQ-5D. value health 19(4), 343–352 (2016)
Google Scholar
Rupel, V., Ogorevc, M.: EQ-5D-5L values established for Slovenia. Pharmacoeconomics. 111515~1524(2023). https://doi.org/10.1007/s40273-023-01280-9
Ramos-Goñi, JM, Craig, BM, Oppe, M., Ramallo-Fariña, Y., Pinto-Prades, JL, Luo, N., Rivero-Arias, O.: Addressing data quality issues for estimating the Spanish EQ-5D-5L value set using a hybrid interval regression approach. value health 21(5), 596–604 (2018)
Google Scholar
Norman, R., Mulhern, B., Lancsar, E., Lorgelly, P., Ratcliffe, J., Street, D., Viney, R.: Use of a discrete choice experiment with both duration and extinction periods to develop EQ-5D-5L values set in Australia. pharmacoeconomics 41(4), 427–438 (2023)
Google Scholar
Chen, YC: A tutorial on kernel density estimation and recent advances. Biostatistics and Epidemiology 1(1), 161–187 (2017)
Google Scholar
Hofstede, G., Hofstede, GJ, Minkov, M.: Culture and Organization: Software of the Mind, vol. 2. McGraw-Hill, New York (2005)
Google Scholar
De Silva, A., van Heusden, A., Lang, Z., Devlin, N., Norman, R., Dalziel, K., Peasgood, T., Pan, T.: How do health status values differ when respondents consider adults and children living in their state? Systematic review. Pharmacoeconomics (2025). https://doi.org/10.1007/s40273-025-01493-0
Google Scholar
